Monday, November 11, 2013
The British Horseracing Authority (BHA) would like to notify BEVA members of a recent update to its Certificate of Non-Contagiousness, to include all licenced UK products for the treatment of ringworm. Norofulvin oral paste and granules have been added to the list, and the dose required for treatment with Imaverol has been included.
There are no other changes to the certificate in terms of information requested. A copy of the new certificate can be found on the BHA's website or by clicking here.
The BHA would like to ask all BEVA members to ensure that the correct form is used for presentation at any future race meetings.
Any queries should be directed to Tessa Muir or Jenny Hall at the BHA
This post was last updated on
Currently rated by 0 people